American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Broadcom
AVGO
|
+$701M |
| 2 |
Mastercard
MA
|
+$306M |
| 3 |
Estee Lauder
EL
|
+$248M |
| 4 |
IQVIA
IQV
|
+$178M |
| 5 |
Arista Networks
ANET
|
+$163M |
Top Sells
| 1 |
Visa
V
|
+$560M |
| 2 |
Advanced Micro Devices
AMD
|
+$524M |
| 3 |
Apple
AAPL
|
+$439M |
| 4 |
NVIDIA
NVDA
|
+$318M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$261M |
Sector Composition
| 1 | Technology | 27.32% |
| 2 | Financials | 13.83% |
| 3 | Consumer Discretionary | 12.65% |
| 4 | Healthcare | 10.02% |
| 5 | Industrials | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Sunstone Hotel Investors
SHO
$1.83B
| $1M | ﹤0.01% |
84,658
-236,815
| -74% | -$2.8M |
|
2252
Ormat Technologies
ORA
$5.55B
| $998K | ﹤0.01% |
14,736
-19
| -0.1% | -$1.29K |
|
2253
Xperi
XPER
$276M
| $993K | ﹤0.01% |
96,651
+8,263
| +9% | +$84.9K |
|
2254
Carriage Services
CSV
$670M
| $992K | ﹤0.01% |
24,892
+2,900
| +13% | +$116K |
|
2255
Olaplex Holdings
OLPX
$954M
| $983K | ﹤0.01% |
568,149
+41,670
| +8% | +$72.1K |
|
2256
Willdan Group
WLDN
$1.45B
| $982K | ﹤0.01% |
25,784
+5,390
| +26% | +$205K |
|
2257
ARS Pharmaceuticals
SPRY
$984M
| $982K | ﹤0.01% |
93,037
-5,412
| -5% | -$57.1K |
|
2258
Excelerate Energy
EE
$764M
| $974K | ﹤0.01% |
32,190
+2,156
| +7% | +$65.2K |
|
2259
Barrett Business Services
BBSI
$1.2B
| $972K | ﹤0.01% |
22,366
-186,319
| -89% | -$8.09M |
|
2260
Varex Imaging
VREX
$477M
| $969K | ﹤0.01% |
66,402
+26,387
| +66% | +$385K |
|
2261
ARKO Corp
ARKO
$574M
| $966K | ﹤0.01% |
146,511
+15,899
| +12% | +$105K |
|
2262
Moog
MOG.A
$6.24B
| $964K | ﹤0.01% |
4,897
+181
| +4% | +$35.6K |
|
|
ONIT
2263
Onity Group Inc.
ONIT
$355M
| $960K | ﹤0.01% |
+31,270
| New | +$960K |
|
2264
Dianthus Therapeutics
DNTH
$1.47B
| $959K | ﹤0.01% |
43,996
+1,629
| +4% | +$35.5K |
|
2265
Haemonetics
HAE
$2.47B
| $958K | ﹤0.01% |
12,274
-234
| -2% | -$18.3K |
|
2266
Upbound Group
UPBD
$1.57B
| $955K | ﹤0.01% |
32,745
+22,410
| +217% | +$654K |
|
2267
Thryv Holdings
THRY
$536M
| $954K | ﹤0.01% |
64,473
+7,970
| +14% | +$118K |
|
2268
Upwork
UPWK
$2.23B
| $950K | ﹤0.01% |
58,103
+3,491
| +6% | +$57.1K |
|
2269
nLIGHT
LASR
$1.48B
| $946K | ﹤0.01% |
90,206
+9,030
| +11% | +$94.7K |
|
2270
Algonquin Power & Utilities
AQN
$4.29B
| $945K | ﹤0.01% |
212,880
+318
| +0.1% | +$1.41K |
|
2271
Dave Inc
DAVE
$2.96B
| $942K | ﹤0.01% |
10,835
+1,383
| +15% | +$120K |
|
|
LENZ
2272
LENZ Therapeutics
LENZ
$1.14B
| $938K | ﹤0.01% |
32,506
+8,631
| +36% | +$249K |
|
2273
Iovance Biotherapeutics
IOVA
$821M
| $937K | ﹤0.01% |
126,654
-72,020
| -36% | -$533K |
|
2274
Kanzhun
BZ
$11.4B
| $932K | ﹤0.01% |
67,567
+26
| +0% | +$359 |
|
2275
Sandstorm Gold
SAND
$3.56B
| $931K | ﹤0.01% |
166,468
+24,056
| +17% | +$135K |
|